![David W. Pritchard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David W. Pritchard
Nessuna posizione attualmente
Profilo
David W.
Pritchard served as President, Chief Executive Officer & Director at Humanigen, Inc. from 2006 to 2014.
Prior to that, he was the Chief Financial Officer & VP-Business Development at CymaBay Therapeutics, Inc. from 1992 to 2000.
He also held positions at Matrix Pharmaceutical, Inc. and Rinat Neuroscience Corp.
as Chief Financial Officer and Chief Business Officer, respectively.
Additionally, he worked as a Principal at Triton Biosciences, Inc. Pritchard holds an MBA from Stanford University and an undergraduate degree from Cornell University.
Precedenti posizioni note di David W. Pritchard
| Società | Posizione | Fine |
|---|---|---|
| HUMANIGEN, INC. | Amministratore Delegato | 08/01/2014 |
| CYMABAY THERAPEUTICS, INC. | Direttore Finanziario/CFO | 01/01/2000 |
Triton Biosciences, Inc. | Corporate Officer/Principal | - |
Matrix Pharmaceutical, Inc.
 Matrix Pharmaceutical, Inc. Medical SpecialtiesHealth Technology Researches and develops pharmaceutical products | Direttore Finanziario/CFO | - |
Rinat Neuroscience Corp.
 Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases | Corporate Officer/Principal | - |
Formazione di David W. Pritchard
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
20
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Matrix Pharmaceutical, Inc.
Matrix Pharmaceutical, Inc. Medical SpecialtiesHealth Technology Researches and develops pharmaceutical products | Health Technology |
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for people with life-threatening diseases | Health Technology |
Humanigen, Inc.
 Humanigen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in development of cell and gene therapies for treatment of cancers and infectious diseases | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rinat Neuroscience Corp.
Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases | Health Technology |
Triton Biosciences, Inc. |
